Pulse 탐색 nav.journalClub 토론 트렌드 연구자

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

홈 탐색 nav.journalClub 트렌드

⌘+K

Ralph K. Lindemann | Synapse

RK

Ralph K. Lindemann

PARP inhibition in cancer therapy

Xenetic Biosciences (United Kingdom)

About

Research focus

PARP inhibition in cancer therapy

Impact

64 pubs · 2,828 cites · h-index 22

Affiliations

Work Experience

Xenetic Biosciences (United Kingdom)

2025 - 2025

Merck (Germany)

2009 - 2024

Howard Hughes Medical Institute

2012 - 2012

The University of Queensland

2012 - 2012

The University of Melbourne

2012 - 2012

Publications